| BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia (NCT00074048) | MedImmune LLC | 2003-10-01 |
| PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia (NCT00362544) | Gilead Sciences | 2003-10-01 |
| Busulfan and Fludarabine in Patients With AML and MDS (NCT00502905) | M.D. Anderson Cancer Center | 2003-10-01 |
| Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant (NCT00534118) | Roswell Park Cancer Institute | 2003-10-01 |
| Oral Valganciclovir Versus Valacyclovir (NCT00562770) | M.D. Anderson Cancer Center | 2003-09-01 |
| Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases (NCT00084695) | Milton S. Hershey Medical Center | 2003-09-01 |
| Genetic Study of Chronic Lymphocytic Leukemia Families (NCT00503256) | M.D. Anderson Cancer Center | 2003-09-01 |
| CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant (NCT00369291) | Masonic Cancer Center, University of Minnesota | 2003-09-01 |
| Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer (NCT00248430) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer (NCT00070382) | Jonsson Comprehensive Cancer Center | 2003-08-01 |
| Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease (NCT00118326) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients (NCT00386373) | M.D. Anderson Cancer Center | 2003-08-01 |
| Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia (NCT00268229) | The Cleveland Clinic | 2003-07-01 |
| VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia (NCT00505700) | Massachusetts General Hospital | 2003-07-01 |
| Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia (NCT00086775) | Bayer | 2003-07-01 |
| Cholecalciferol in Treating Patients With Myelodysplastic Syndrome (NCT00068276) | Wake Forest University Health Sciences | 2003-07-01 |
| Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets (NCT00074763) | M.D. Anderson Cancer Center | 2003-07-01 |
| Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia (NCT00281918) | Hoffmann-La Roche | 2003-07-01 |
| Molecular Epidemiology of Acute Myelogenous Leukemia (NCT00502983) | M.D. Anderson Cancer Center | 2003-06-23 |
| Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer (NCT00064285) | Virginia Commonwealth University | 2003-06-01 |
| Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy (NCT00066599) | National Cancer Institute (NCI) | 2003-06-01 |
| Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies (NCT00068523) | Case Comprehensive Cancer Center | 2003-06-01 |
| Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia (NCT00066326) | Barbara Ann Karmanos Cancer Institute | 2003-06-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Epoetin Alfa in Treating Anemia in Patients With Solid Tumors (NCT00058331) | Alliance for Clinical Trials in Oncology | 2003-06-01 |
| VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies (NCT00070538) | Vion Pharmaceuticals | 2003-06-01 |
| Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment (NCT00066248) | University of South Florida | 2003-06-01 |
| Paricalcitol in Treating Patients With Myelodysplastic Syndrome (NCT00064376) | Cedars-Sinai Medical Center | 2003-05-01 |
| Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment (NCT00072579) | Wake Forest University Health Sciences | 2003-05-01 |
| Phase I Study of Sequential Cord Blood Transplants (NCT00299767) | Massachusetts General Hospital | 2003-05-01 |
| Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML (NCT00416884) | OHSU Knight Cancer Institute | 2003-05-01 |
| Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00062140) | Fred Hutchinson Cancer Center | 2003-04-01 |
| S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia (NCT00049179) | SWOG Cancer Research Network | 2003-04-01 |
| S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia (NCT00053014) | SWOG Cancer Research Network | 2003-04-01 |
| Study of @neWorld: A Virtual Community for Children With Cancer (NCT00070421) | Leap of Faith Technologies | 2003-04-01 |
| Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma (NCT00631579) | Sanofi | 2003-04-01 |
| Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00112567) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation Chemotherapy (NCT01099202) | M.D. Anderson Cancer Center | 2003-03-01 |
| Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies (NCT00185640) | Stanford University | 2003-03-01 |
| Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00062296) | Fox Chase Cancer Center | 2003-03-01 |
| 3-AP and Cytarabine in Treating Patients With Hematologic Cancer (NCT00064090) | Vion Pharmaceuticals | 2003-03-01 |
| Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate (NCT00156299) | Rutgers, The State University of New Jersey | 2003-03-01 |
| A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies (NCT00621244) | Novartis Pharmaceuticals | 2003-03-01 |
| Natural History Study of Patients With Chronic Myelogenous Leukemia (NCT00429910) | Dana-Farber Cancer Institute | 2003-02-01 |
| Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (NCT00499889) | M.D. Anderson Cancer Center | 2003-02-01 |
| Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath (NCT00580034) | David Rizzieri, MD | 2003-02-01 |
| Exercise Program for Adolescents and Young Adults With Cancer (NCT00502749) | M.D. Anderson Cancer Center | 2003-02-01 |
| Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation (NCT00057005) | Baylor College of Medicine | 2003-02-01 |
| Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders (NCT00055653) | Roswell Park Cancer Institute | 2003-01-01 |
| C-Reactive Protein as a Predictor of Stem Cell Transplant Complications (NCT00179868) | Ann & Robert H Lurie Children's Hospital of Chicago | 2003-01-01 |
| Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer (NCT00627666) | Asan Medical Center | 2003-01-01 |
| Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (NCT00078520) | Baylor College of Medicine | 2003-01-01 |
| Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia (NCT00343369) | Universitätsklinikum Hamburg-Eppendorf | 2003-01-01 |
| Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma (NCT00068302) | Children's Hospital of Philadelphia | 2003-01-01 |
| Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer (NCT00301860) | University of California, San Francisco | 2003-01-01 |
| Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF (NCT00952237) | Dartmouth-Hitchcock Medical Center | 2003-01-01 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia (NCT00049517) | Eastern Cooperative Oncology Group | 2002-12-19 |
| Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer (NCT00265837) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer (NCT00053196) | Alliance for Clinical Trials in Oncology | 2002-12-01 |
| Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia (NCT00056069) | Children's Oncology Group | 2002-12-01 |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia (NCT00671658) | M.D. Anderson Cancer Center | 2002-11-01 |
| Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia (NCT00022126) | Children's Oncology Group | 2002-11-01 |
| Unrelated Donor Transplant for Malignant and Non-Malignant Disorders (NCT01050439) | Columbia University | 2002-11-01 |
| Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies (NCT00113646) | Massachusetts General Hospital | 2002-11-01 |
| Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia (NCT00764907) | University Hospital, Motol | 2002-11-01 |
| Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT00967057) | Children's Cancer and Leukaemia Group | 2002-10-01 |
| Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders (NCT00052572) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00052416) | Beth Israel Deaconess Medical Center | 2002-10-01 |
| Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies (NCT00048737) | M.D. Anderson Cancer Center | 2002-10-01 |
| Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder (NCT00054340) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00058396) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia (NCT00053248) | OHSU Knight Cancer Institute | 2002-10-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer (NCT00304018) | University of California, San Francisco | 2002-10-01 |
| Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia (NCT00046930) | Eastern Cooperative Oncology Group | 2002-09-17 |
| Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS (NCT00053287) | Case Comprehensive Cancer Center | 2002-09-01 |
| Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00052299) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-09-01 |
| Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine (NCT00274976) | German CLL Study Group | 2002-09-01 |
| Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT00052832) | University of Wisconsin, Madison | 2002-09-01 |
| Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia (NCT00049075) | NCIC Clinical Trials Group | 2002-08-08 |
| Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia (NCT00021242) | Children's Oncology Group | 2002-08-01 |
| Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia (NCT00082940) | Wake Forest University Health Sciences | 2002-08-01 |
| Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer (NCT00255710) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-07-01 |
| Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma (NCT00082303) | National Center for Complementary and Integrative Health (NCCIH) | 2002-07-01 |
| Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00028899) | Children's Oncology Group | 2002-07-01 |
| Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (NCT00055874) | Heidelberg University | 2002-06-01 |
| Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia (NCT00053157) | Roswell Park Cancer Institute | 2002-06-01 |
| Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma (NCT00045513) | University Health Network, Toronto | 2002-06-01 |
| Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers (NCT00899795) | OHSU Knight Cancer Institute | 2002-06-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma (NCT00049413) | Hoag Memorial Hospital Presbyterian | 2002-06-01 |
| Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL (NCT00072007) | Swiss Cancer Institute | 2002-06-01 |
| Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia (NCT00054236) | Case Comprehensive Cancer Center | 2002-05-01 |
| Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia (NCT00039130) | Alliance for Clinical Trials in Oncology | 2002-05-01 |
| Dysregulated Tyrosine Kinase Signaling in Leukemia (NCT00277056) | University of New Mexico | 2002-05-01 |
| Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) (NCT00185523) | Stanford University | 2002-05-01 |
| FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma (NCT00042822) | Memorial Sloan Kettering Cancer Center | 2002-05-01 |
| Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia (NCT00096018) | Roswell Park Cancer Institute | 2002-05-01 |
| Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome (NCT00043134) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-05-01 |
| Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen (NCT00774280) | Cooperative Study Group A for Hematology | 2002-05-01 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |